Collaboration Opportunities Ichor Medical Systems has a history of collaborating with prominent companies like AstraZeneca, Immunomic Therapeutics, and BioHealth Innovation, indicating potential partnership opportunities for joint ventures or research projects.

Diverse Disease Indications With a focus on DNA drugs and vaccines for diseases such as cancer, hepatitis B virus, HIV, Ebola, and biodefense agents, Ichor presents sales opportunities for tailored solutions across a range of healthcare sectors.

Technological Innovation Utilizing advanced technology like the TriGrid Delivery System, Ichor Medical Systems offers cutting-edge solutions that could appeal to clients seeking innovative and efficient DNA administration platforms.

Expanding Global Presence Having collaborations on three continents and ongoing studies targeting diseases worldwide, Ichor's international footprint suggests potential avenues for sales expansion into diverse geographic markets.

Strategic Funding Needs With revenue in the range of $0-10M and undisclosed funding, Ichor may have requirements for financial support, presenting sales opportunities for financial institutions or investors looking to partner with a growing biotech company.